Clinical Trial Update: Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the pharmacokinetics and pharmacodynamics of daily enteric-coated aspirin in adults with stable type 2 diabetes; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Enteric-coated aspirin (acetylsalicylic acid)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Platelet Aggregation, Type 2 Diabetes | Phase 1 | Status: RECRUITING